International Heart and Vascular Disease Journal

International Heart and Vascular Disease Journal

The International Heart and Vascular Disease Journal is a peer-reviewed medical journal for specialists in cardiology. The journal is published four times a year in two languages (English and Russian), in both print and digital formats. The limited-distribution print version is provided for free. All issues are available for free online at, www.cardioprogress.ru.

The journal was registered by the Ministry for Press, Broadcasting and Mass Communications of Russian Federation on 30.07.2013 (PI № FS 77-54594).

ISSN (Print): 2309-0901
ISSN (Online): 2311-1631

The format of publications

The journal publishes papers on original research, review articles, case reports, expert opinions, guidelines, editorials, discussions, and letters to the Editor-in-Chief.

Main topics

Publication of scientific materials and articles for authors is free of charge.

Circulation is 3000 copies. Published in Russia

Official site: heart-vdj.com

Scientific news

  • A Week of Anticoagulation Halves Post-PCI Radial Occlusion Rate BOSTON — Following transradial access for angiography or a percutaneous coronary intervention (PCI), a low dose of the factor Xa inhibitor rivaroxaban for 7 days reduces the risk of an access-site occlusion by 50%, according to results of the randomized RIVARAD trial.

  • Expert Consensus Guides Use of Cardiac CT in Patients With Cancer The Society of Cardiovascular Computed Tomography (SCCT) has issued an expert consensus statement to guide use of cardiac computed tomography (CCT) in the care of cardio-oncology patients.

  • Frailty Poses No Limit to HFpEF Meds BARCELONA — Increased frailty of patients with heart failure with preserved ejection fraction (HFpEF) should have no bearing on whether those patients receive sacubitril/valsartan (Entresto), according to results of a post hoc analysis of data from a pivotal trial.

  • PASCAL for MV Repair Noninferior to MitraClip in CLASP IID, FDA Took Notice A newly available transcatheter device for edge-to-edge mitral valve (MV) repair, named for a famed scientist-inventor, is similar to the long-available MitraClip (Abbott) for short-term efficacy and safety, suggests an interim but prespecified analysis from a randomized trial.

  • How Does Salt Intake Relate to Mortality? Intake of salt is a biological necessity, inextricably woven into physiologic systems. However, excessive salt intake is associated with high blood pressure. Hypertension is linked to increased cardiovascular morbidity and mortality, and it is estimated that excessive salt intake causes approximately 5 million deaths per year worldwide. Reducing salt intake lowers blood pressure, but processed foods contain "hidden" salt, which makes dietary control of salt difficult. This problem is compounded by growing inequalities in food systems, which present another hurdle to sustaining individual dietary control of salt intake.

Video resource

Follow us

Top.Mail.Ru